To Bev or Not to Bev during Ovarian Cancer Maintenance Therapy?

Published in: Cancers (2023)

The presented guidelines offer an evidence-based framework for selecting the most effective maintenance therapy for ovarian cancer patients. Further research is necessary to refine these recommendations and improve outcomes for patients with this disease.

Keyphrases

cell therapy
stem cells
clinical practice
mesenchymal stem cells
type diabetes
insulin resistance
metabolic syndrome
bone marrow
glycemic control
replacement therapy